Hua Shen Technology: Intends to transfer drug marketing approval and related technology to an external party.

Huashen Technology announced that its subsidiary, Huashen Pharmaceutical Factory, plans to transfer its ownership of "no-smoke moxibustion strip market approval rights and related technologies" to Sichuan Binjiang Pharmaceutical Co., Ltd. The total transfer amount is 18 million RMB. At the same time, the company will invest 4.5556 million RMB to acquire a 10% stake in Shanghai Aixingcheng Technology Co., Ltd. This transaction is subject to approval by the company's shareholders' meeting before it can be executed.